

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | chaperone-mediated protein transport (GO:0072321) | 6.06007915 |
| 2 | DNA deamination (GO:0045006) | 6.01583786 |
| 3 | positive regulation of defense response to virus by host (GO:0002230) | 5.16244826 |
| 4 | interferon-gamma production (GO:0032609) | 4.81198482 |
| 5 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.56828041 |
| 6 | leukocyte aggregation (GO:0070486) | 4.48015651 |
| 7 | activation of MAPKKK activity (GO:0000185) | 4.34717239 |
| 8 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.26561187 |
| 9 | ATP synthesis coupled proton transport (GO:0015986) | 4.26561187 |
| 10 | cellular response to interleukin-15 (GO:0071350) | 4.19562049 |
| 11 | GDP-mannose metabolic process (GO:0019673) | 4.18325564 |
| 12 | nucleoside transmembrane transport (GO:1901642) | 4.07812967 |
| 13 | piRNA metabolic process (GO:0034587) | 4.03199902 |
| 14 | positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517) | 3.95743091 |
| 15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.79631446 |
| 16 | ribosomal small subunit assembly (GO:0000028) | 3.67977539 |
| 17 | viral transcription (GO:0019083) | 3.64953096 |
| 18 | cytidine metabolic process (GO:0046087) | 3.60765389 |
| 19 | cytidine catabolic process (GO:0006216) | 3.60765389 |
| 20 | cytidine deamination (GO:0009972) | 3.60765389 |
| 21 | regulation of defense response to virus by host (GO:0050691) | 3.60467628 |
| 22 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.54942164 |
| 23 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.48748569 |
| 24 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.48748569 |
| 25 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 3.47152469 |
| 26 | mast cell activation (GO:0045576) | 3.44795893 |
| 27 | translational termination (GO:0006415) | 3.39943706 |
| 28 | translational elongation (GO:0006414) | 3.39812861 |
| 29 | regulation of regulatory T cell differentiation (GO:0045589) | 3.33329396 |
| 30 | sleep (GO:0030431) | 3.28565152 |
| 31 | mast cell activation involved in immune response (GO:0002279) | 3.25875782 |
| 32 | mast cell degranulation (GO:0043303) | 3.25875782 |
| 33 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.25759815 |
| 34 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.23834413 |
| 35 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.19565596 |
| 36 | response to pheromone (GO:0019236) | 3.18926652 |
| 37 | endoderm formation (GO:0001706) | 3.17855035 |
| 38 | response to interleukin-15 (GO:0070672) | 3.16038405 |
| 39 | mannose metabolic process (GO:0006013) | 3.14887074 |
| 40 | ribosomal small subunit biogenesis (GO:0042274) | 3.13465817 |
| 41 | glycoprotein catabolic process (GO:0006516) | 3.10298958 |
| 42 | positive regulation of fatty acid transport (GO:2000193) | 3.05238884 |
| 43 | rRNA transcription (GO:0009303) | 3.04404791 |
| 44 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.03096905 |
| 45 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.02552234 |
| 46 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.99860688 |
| 47 | cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) | 2.97180009 |
| 48 | nucleoside transport (GO:0015858) | 2.97077186 |
| 49 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.96631792 |
| 50 | DNA methylation involved in gamete generation (GO:0043046) | 2.94567844 |
| 51 | cellular response to exogenous dsRNA (GO:0071360) | 2.94161765 |
| 52 | positive thymic T cell selection (GO:0045059) | 2.91354965 |
| 53 | positive regulation of icosanoid secretion (GO:0032305) | 2.91350665 |
| 54 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.90366727 |
| 55 | termination of RNA polymerase III transcription (GO:0006386) | 2.90207155 |
| 56 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.90207155 |
| 57 | positive regulation of signal transduction by p53 class mediator (GO:1901798) | 2.89896845 |
| 58 | pseudouridine synthesis (GO:0001522) | 2.88986282 |
| 59 | dendritic cell chemotaxis (GO:0002407) | 2.85400418 |
| 60 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.83566305 |
| 61 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.79980590 |
| 62 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.77065344 |
| 63 | protein targeting to ER (GO:0045047) | 2.76630644 |
| 64 | reciprocal meiotic recombination (GO:0007131) | 2.72032385 |
| 65 | reciprocal DNA recombination (GO:0035825) | 2.72032385 |
| 66 | tolerance induction (GO:0002507) | 2.71174236 |
| 67 | cotranslational protein targeting to membrane (GO:0006613) | 2.71026979 |
| 68 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.68701836 |
| 69 | behavioral response to nicotine (GO:0035095) | 2.68615242 |
| 70 | pantothenate metabolic process (GO:0015939) | 2.68367164 |
| 71 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.68021078 |
| 72 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.64129825 |
| 73 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.61932623 |
| 74 | protein localization to endoplasmic reticulum (GO:0070972) | 2.59771863 |
| 75 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.58334326 |
| 76 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.58289579 |
| 77 | negative regulation of mast cell activation (GO:0033004) | 2.54965308 |
| 78 | viral life cycle (GO:0019058) | 2.53801415 |
| 79 | T cell receptor signaling pathway (GO:0050852) | 2.53486190 |
| 80 | fucose catabolic process (GO:0019317) | 2.51595043 |
| 81 | L-fucose metabolic process (GO:0042354) | 2.51595043 |
| 82 | L-fucose catabolic process (GO:0042355) | 2.51595043 |
| 83 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.50984605 |
| 84 | maturation of SSU-rRNA (GO:0030490) | 2.50474746 |
| 85 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.48217577 |
| 86 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.48217577 |
| 87 | T cell migration (GO:0072678) | 2.48192948 |
| 88 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.47508993 |
| 89 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.47307397 |
| 90 | positive regulation of T cell mediated immunity (GO:0002711) | 2.46721027 |
| 91 | negative T cell selection (GO:0043383) | 2.44211082 |
| 92 | regulation of germinal center formation (GO:0002634) | 2.42827612 |
| 93 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.42646067 |
| 94 | cellular protein complex disassembly (GO:0043624) | 2.41984828 |
| 95 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.39988620 |
| 96 | indolalkylamine metabolic process (GO:0006586) | 2.39836374 |
| 97 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.39347160 |
| 98 | response to interferon-beta (GO:0035456) | 2.39280582 |
| 99 | meiotic chromosome segregation (GO:0045132) | 2.38878067 |
| 100 | negative regulation of cell killing (GO:0031342) | 2.36619098 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.10331921 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.40776852 |
| 3 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 4.14074116 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.88436640 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.21196161 |
| 6 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.07814184 |
| 7 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.84535471 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.73063897 |
| 9 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.67654548 |
| 10 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.58136079 |
| 11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.42774552 |
| 12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.40111699 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 2.24558963 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.18868815 |
| 15 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.13046395 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.08821725 |
| 17 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.05010044 |
| 18 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.96661442 |
| 19 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.95050637 |
| 20 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.94755082 |
| 21 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.87942530 |
| 22 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.87869727 |
| 23 | GATA3_26560356_Chip-Seq_TH2_Human | 1.84884848 |
| 24 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.81544373 |
| 25 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.78394474 |
| 26 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.76922979 |
| 27 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.75330290 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 1.72577414 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.70138506 |
| 30 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.59942373 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58312370 |
| 32 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.57628147 |
| 33 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.52850678 |
| 34 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.51336681 |
| 35 | AR_20517297_ChIP-Seq_VCAP_Human | 1.49369955 |
| 36 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.46992250 |
| 37 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.45578945 |
| 38 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.45404569 |
| 39 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.44004389 |
| 40 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.42537211 |
| 41 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.37886047 |
| 42 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.36726826 |
| 43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.36242330 |
| 44 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.34926039 |
| 45 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.34926039 |
| 46 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.31009025 |
| 47 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.30812713 |
| 48 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.29774674 |
| 49 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.28419025 |
| 50 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.28323384 |
| 51 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.28029060 |
| 52 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.26688569 |
| 53 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.25483851 |
| 54 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.24930729 |
| 55 | NCOR_22424771_ChIP-Seq_293T_Human | 1.24182946 |
| 56 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.23306509 |
| 57 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.23274698 |
| 58 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.22667326 |
| 59 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19409925 |
| 60 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.19092904 |
| 61 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.18984896 |
| 62 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.18501034 |
| 63 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.17863796 |
| 64 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16317739 |
| 65 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15469613 |
| 66 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.14871998 |
| 67 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.14649782 |
| 68 | ERA_21632823_ChIP-Seq_H3396_Human | 1.13272862 |
| 69 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12970017 |
| 70 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.12482951 |
| 71 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.10825823 |
| 72 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.09136497 |
| 73 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.09115465 |
| 74 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.08051047 |
| 75 | P300_27268052_Chip-Seq_Bcells_Human | 1.07234568 |
| 76 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.06650817 |
| 77 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.06560500 |
| 78 | GATA3_26560356_Chip-Seq_TH1_Human | 1.04710484 |
| 79 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.04305738 |
| 80 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.03264560 |
| 81 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02793398 |
| 82 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.02411473 |
| 83 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.00089559 |
| 84 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.99815854 |
| 85 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.99452537 |
| 86 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.99255008 |
| 87 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.98482648 |
| 88 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.97409697 |
| 89 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.94905228 |
| 90 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.94717754 |
| 91 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.94711770 |
| 92 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.94683374 |
| 93 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.94532580 |
| 94 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.94107825 |
| 95 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.93565819 |
| 96 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.93334251 |
| 97 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.92208436 |
| 98 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92176588 |
| 99 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.91743517 |
| 100 | FUS_26573619_Chip-Seq_HEK293_Human | 0.90761791 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.85904173 |
| 2 | MP0002638_abnormal_pupillary_reflex | 3.12658084 |
| 3 | MP0003724_increased_susceptibility_to | 2.91676939 |
| 4 | MP0005623_abnormal_meninges_morphology | 2.77386554 |
| 5 | MP0006072_abnormal_retinal_apoptosis | 2.71342555 |
| 6 | MP0005360_urolithiasis | 2.67402619 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.62809852 |
| 8 | MP0004147_increased_porphyrin_level | 2.60885901 |
| 9 | MP0000013_abnormal_adipose_tissue | 2.58891890 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.39282424 |
| 11 | MP0001800_abnormal_humoral_immune | 2.38937337 |
| 12 | MP0003646_muscle_fatigue | 2.34872110 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.25886432 |
| 14 | MP0003436_decreased_susceptibility_to | 2.20199158 |
| 15 | MP0000685_abnormal_immune_system | 2.09480618 |
| 16 | MP0004947_skin_inflammation | 2.01580320 |
| 17 | MP0003763_abnormal_thymus_physiology | 2.00405559 |
| 18 | MP0002723_abnormal_immune_serum | 1.94982836 |
| 19 | MP0009785_altered_susceptibility_to | 1.93747352 |
| 20 | MP0001790_abnormal_immune_system | 1.93483159 |
| 21 | MP0005387_immune_system_phenotype | 1.93483159 |
| 22 | MP0003786_premature_aging | 1.90077370 |
| 23 | MP0005646_abnormal_pituitary_gland | 1.89622392 |
| 24 | MP0009764_decreased_sensitivity_to | 1.88672667 |
| 25 | MP0004043_abnormal_pH_regulation | 1.86022784 |
| 26 | MP0004885_abnormal_endolymph | 1.85416480 |
| 27 | MP0002420_abnormal_adaptive_immunity | 1.80961668 |
| 28 | MP0001819_abnormal_immune_cell | 1.80367820 |
| 29 | MP0002452_abnormal_antigen_presenting | 1.79917636 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 1.71731659 |
| 31 | MP0001986_abnormal_taste_sensitivity | 1.66379024 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.65954303 |
| 33 | MP0008875_abnormal_xenobiotic_pharmacok | 1.65756818 |
| 34 | MP0001873_stomach_inflammation | 1.63864954 |
| 35 | MP0003866_abnormal_defecation | 1.61846048 |
| 36 | MP0005025_abnormal_response_to | 1.58490793 |
| 37 | MP0009379_abnormal_foot_pigmentation | 1.57297853 |
| 38 | MP0002876_abnormal_thyroid_physiology | 1.54357348 |
| 39 | MP0008872_abnormal_physiological_respon | 1.50927726 |
| 40 | MP0002138_abnormal_hepatobiliary_system | 1.50752224 |
| 41 | MP0005551_abnormal_eye_electrophysiolog | 1.46969836 |
| 42 | MP0000372_irregular_coat_pigmentation | 1.46250096 |
| 43 | MP0008775_abnormal_heart_ventricle | 1.40846113 |
| 44 | MP0001501_abnormal_sleep_pattern | 1.36560976 |
| 45 | MP0009384_cardiac_valve_regurgitation | 1.33890409 |
| 46 | MP0005075_abnormal_melanosome_morpholog | 1.33435216 |
| 47 | MP0003011_delayed_dark_adaptation | 1.33021171 |
| 48 | MP0002933_joint_inflammation | 1.32225560 |
| 49 | MP0005389_reproductive_system_phenotype | 1.30259352 |
| 50 | MP0000750_abnormal_muscle_regeneration | 1.28923562 |
| 51 | MP0002419_abnormal_innate_immunity | 1.26356524 |
| 52 | MP0001845_abnormal_inflammatory_respons | 1.24420203 |
| 53 | MP0000858_altered_metastatic_potential | 1.23956172 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.23334210 |
| 55 | MP0002398_abnormal_bone_marrow | 1.20939372 |
| 56 | MP0000689_abnormal_spleen_morphology | 1.20810251 |
| 57 | MP0000716_abnormal_immune_system | 1.19407482 |
| 58 | MP0002938_white_spotting | 1.18674877 |
| 59 | MP0005464_abnormal_platelet_physiology | 1.18076375 |
| 60 | MP0005253_abnormal_eye_physiology | 1.15776157 |
| 61 | MP0006082_CNS_inflammation | 1.15443456 |
| 62 | MP0001919_abnormal_reproductive_system | 1.11912064 |
| 63 | MP0002006_tumorigenesis | 1.11318324 |
| 64 | MP0002277_abnormal_respiratory_mucosa | 1.09727251 |
| 65 | MP0002166_altered_tumor_susceptibility | 1.05750645 |
| 66 | MP0002722_abnormal_immune_system | 1.05090910 |
| 67 | MP0008469_abnormal_protein_level | 1.01357018 |
| 68 | MP0002102_abnormal_ear_morphology | 0.99793116 |
| 69 | MP0002837_dystrophic_cardiac_calcinosis | 0.98929860 |
| 70 | MP0003638_abnormal_response/metabolism_ | 0.98480746 |
| 71 | MP0002736_abnormal_nociception_after | 0.97739086 |
| 72 | MP0001968_abnormal_touch/_nociception | 0.97262094 |
| 73 | MP0002429_abnormal_blood_cell | 0.96878117 |
| 74 | MP0004130_abnormal_muscle_cell | 0.96715529 |
| 75 | MP0000465_gastrointestinal_hemorrhage | 0.96253222 |
| 76 | MP0001542_abnormal_bone_strength | 0.95443502 |
| 77 | MP0001765_abnormal_ion_homeostasis | 0.93008710 |
| 78 | MP0003195_calcinosis | 0.89681230 |
| 79 | MP0001905_abnormal_dopamine_level | 0.89188522 |
| 80 | MP0002160_abnormal_reproductive_system | 0.88825479 |
| 81 | MP0005410_abnormal_fertilization | 0.87699392 |
| 82 | MP0009765_abnormal_xenobiotic_induced | 0.86124937 |
| 83 | MP0005332_abnormal_amino_acid | 0.84863577 |
| 84 | MP0005174_abnormal_tail_pigmentation | 0.83505865 |
| 85 | MP0002019_abnormal_tumor_incidence | 0.83041601 |
| 86 | MP0008877_abnormal_DNA_methylation | 0.81837143 |
| 87 | MP0002163_abnormal_gland_morphology | 0.80806963 |
| 88 | MP0005645_abnormal_hypothalamus_physiol | 0.79549538 |
| 89 | MP0000703_abnormal_thymus_morphology | 0.78851411 |
| 90 | MP0002405_respiratory_system_inflammati | 0.78671929 |
| 91 | MP0002139_abnormal_hepatobiliary_system | 0.78594657 |
| 92 | MP0004145_abnormal_muscle_electrophysio | 0.74242817 |
| 93 | MP0005085_abnormal_gallbladder_physiolo | 0.70409194 |
| 94 | MP0008873_increased_physiological_sensi | 0.69442972 |
| 95 | MP0006036_abnormal_mitochondrial_physio | 0.66321617 |
| 96 | MP0005636_abnormal_mineral_homeostasis | 0.64970590 |
| 97 | MP0008995_early_reproductive_senescence | 0.64866152 |
| 98 | MP0005390_skeleton_phenotype | 0.63986609 |
| 99 | MP0005084_abnormal_gallbladder_morpholo | 0.63705391 |
| 100 | MP0009643_abnormal_urine_homeostasis | 0.63642698 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cerebellar dysplasia (HP:0007033) | 6.63845209 |
| 2 | Type II lissencephaly (HP:0007260) | 6.60731384 |
| 3 | Hypoplasia of the pons (HP:0012110) | 5.96546824 |
| 4 | Abnormality of the pons (HP:0007361) | 5.70357710 |
| 5 | Retinal atrophy (HP:0001105) | 5.55146813 |
| 6 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 5.47729479 |
| 7 | IgG deficiency (HP:0004315) | 4.86025904 |
| 8 | Retinal dysplasia (HP:0007973) | 4.81781642 |
| 9 | Abolished electroretinogram (ERG) (HP:0000550) | 4.01758706 |
| 10 | Fatigue (HP:0012378) | 3.73461447 |
| 11 | Buphthalmos (HP:0000557) | 3.64236296 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.61727971 |
| 13 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 3.41568534 |
| 14 | Severe muscular hypotonia (HP:0006829) | 3.08851430 |
| 15 | Global brain atrophy (HP:0002283) | 3.04166837 |
| 16 | Abnormality of alanine metabolism (HP:0010916) | 2.90585141 |
| 17 | Hyperalaninemia (HP:0003348) | 2.90585141 |
| 18 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.90585141 |
| 19 | Congenital stationary night blindness (HP:0007642) | 2.84419091 |
| 20 | T lymphocytopenia (HP:0005403) | 2.80172676 |
| 21 | Abnormality of eosinophils (HP:0001879) | 2.70868499 |
| 22 | 3-Methylglutaconic aciduria (HP:0003535) | 2.60133077 |
| 23 | Eosinophilia (HP:0001880) | 2.48496369 |
| 24 | Abnormality of T cell number (HP:0011839) | 2.44497517 |
| 25 | Hypobetalipoproteinemia (HP:0003563) | 2.39918408 |
| 26 | Methylmalonic acidemia (HP:0002912) | 2.39857945 |
| 27 | Conical tooth (HP:0000698) | 2.34308563 |
| 28 | Abnormality of the renal cortex (HP:0011035) | 2.32290348 |
| 29 | Increased CSF lactate (HP:0002490) | 2.30916611 |
| 30 | Congenital glaucoma (HP:0001087) | 2.30484535 |
| 31 | Nephronophthisis (HP:0000090) | 2.27375865 |
| 32 | Lipid accumulation in hepatocytes (HP:0006561) | 2.25414819 |
| 33 | Dyskinesia (HP:0100660) | 2.24310459 |
| 34 | Myositis (HP:0100614) | 2.23275262 |
| 35 | Mitochondrial inheritance (HP:0001427) | 2.22711165 |
| 36 | Difficulty climbing stairs (HP:0003551) | 2.20363728 |
| 37 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.20096470 |
| 38 | Type 2 muscle fiber atrophy (HP:0003554) | 2.19595173 |
| 39 | Severe combined immunodeficiency (HP:0004430) | 2.19303581 |
| 40 | Molar tooth sign on MRI (HP:0002419) | 2.19048191 |
| 41 | Abnormality of midbrain morphology (HP:0002418) | 2.19048191 |
| 42 | Abnormality of T cells (HP:0002843) | 2.16711332 |
| 43 | Generalized muscle weakness (HP:0003324) | 2.15801603 |
| 44 | Brushfield spots (HP:0001088) | 2.14766330 |
| 45 | Akinesia (HP:0002304) | 2.14486953 |
| 46 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.09726338 |
| 47 | Methylmalonic aciduria (HP:0012120) | 2.09631023 |
| 48 | Pachygyria (HP:0001302) | 2.08115647 |
| 49 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.07142485 |
| 50 | Hepatocellular necrosis (HP:0001404) | 2.06632216 |
| 51 | Attenuation of retinal blood vessels (HP:0007843) | 2.04841394 |
| 52 | Hepatic necrosis (HP:0002605) | 2.01982713 |
| 53 | Medial flaring of the eyebrow (HP:0010747) | 2.01381022 |
| 54 | IgM deficiency (HP:0002850) | 2.00355643 |
| 55 | Increased hepatocellular lipid droplets (HP:0006565) | 2.00116691 |
| 56 | Lissencephaly (HP:0001339) | 1.99713216 |
| 57 | Increased IgM level (HP:0003496) | 1.99195487 |
| 58 | Acanthocytosis (HP:0001927) | 1.98985116 |
| 59 | Hypoplasia of the brainstem (HP:0002365) | 1.98974016 |
| 60 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.98974016 |
| 61 | Neurodegeneration (HP:0002180) | 1.98848025 |
| 62 | Increased serum lactate (HP:0002151) | 1.98428818 |
| 63 | Pancreatic cysts (HP:0001737) | 1.96621957 |
| 64 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.95047271 |
| 65 | Muscle fiber atrophy (HP:0100295) | 1.94776258 |
| 66 | Stomatitis (HP:0010280) | 1.94516166 |
| 67 | Abnormality of the renal medulla (HP:0100957) | 1.94317764 |
| 68 | Abnormal number of erythroid precursors (HP:0012131) | 1.92016911 |
| 69 | Metabolic alkalosis (HP:0200114) | 1.91638768 |
| 70 | Leukocytosis (HP:0001974) | 1.90043244 |
| 71 | Hypoproteinemia (HP:0003075) | 1.89934517 |
| 72 | Granulocytopenia (HP:0001913) | 1.89144117 |
| 73 | Panhypogammaglobulinemia (HP:0003139) | 1.89069215 |
| 74 | Orchitis (HP:0100796) | 1.88810574 |
| 75 | Retrobulbar optic neuritis (HP:0100654) | 1.88621684 |
| 76 | Optic neuritis (HP:0100653) | 1.88621684 |
| 77 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.88619377 |
| 78 | Encephalitis (HP:0002383) | 1.87631219 |
| 79 | Abnormal albumin level (HP:0012116) | 1.86966035 |
| 80 | Hypoalbuminemia (HP:0003073) | 1.86966035 |
| 81 | Intellectual disability, profound (HP:0002187) | 1.86288524 |
| 82 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.83635102 |
| 83 | Pallor (HP:0000980) | 1.83262907 |
| 84 | Stomach cancer (HP:0012126) | 1.80593829 |
| 85 | Severe global developmental delay (HP:0011344) | 1.80031047 |
| 86 | Renal cortical cysts (HP:0000803) | 1.79145468 |
| 87 | Hypoplasia of the uterus (HP:0000013) | 1.77928322 |
| 88 | Pancreatic fibrosis (HP:0100732) | 1.77329159 |
| 89 | Increased intramyocellular lipid droplets (HP:0012240) | 1.76905273 |
| 90 | Acute necrotizing encephalopathy (HP:0006965) | 1.76019416 |
| 91 | Keratitis (HP:0000491) | 1.74628027 |
| 92 | Mesangial abnormality (HP:0001966) | 1.74427807 |
| 93 | Decreased circulating renin level (HP:0003351) | 1.73218948 |
| 94 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.73151358 |
| 95 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.70833054 |
| 96 | Absent/shortened dynein arms (HP:0200106) | 1.70833054 |
| 97 | Hyperglycinemia (HP:0002154) | 1.70627959 |
| 98 | Increased muscle lipid content (HP:0009058) | 1.70262238 |
| 99 | Non-midline cleft lip (HP:0100335) | 1.69616536 |
| 100 | Megalocornea (HP:0000485) | 1.69042620 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 6.48886998 |
| 2 | TXK | 4.56001171 |
| 3 | TLK1 | 3.93962121 |
| 4 | ZAK | 3.57782018 |
| 5 | MARK3 | 3.03863510 |
| 6 | STK10 | 2.92283195 |
| 7 | MAP4K2 | 2.79143180 |
| 8 | ADRBK2 | 2.36120389 |
| 9 | MAP2K2 | 2.27252661 |
| 10 | BCKDK | 2.08716856 |
| 11 | MAP4K1 | 2.08600908 |
| 12 | KIT | 1.99130907 |
| 13 | PIM1 | 1.90171389 |
| 14 | GRK6 | 1.89002951 |
| 15 | PDK2 | 1.73263264 |
| 16 | MAPKAPK3 | 1.73091208 |
| 17 | FES | 1.62655998 |
| 18 | IKBKB | 1.52750495 |
| 19 | NUAK1 | 1.49993601 |
| 20 | GRK1 | 1.43025553 |
| 21 | FRK | 1.41940101 |
| 22 | PINK1 | 1.37735138 |
| 23 | ITK | 1.36130941 |
| 24 | SYK | 1.27528565 |
| 25 | MAP3K14 | 1.21976271 |
| 26 | TEC | 1.20935566 |
| 27 | TNK2 | 1.20872025 |
| 28 | KDR | 1.19516345 |
| 29 | WNK4 | 1.19490824 |
| 30 | PTK2B | 1.16939973 |
| 31 | CAMKK2 | 1.16059443 |
| 32 | MATK | 1.11287147 |
| 33 | CSF1R | 1.09306149 |
| 34 | BMPR1B | 1.08233736 |
| 35 | LCK | 1.07552351 |
| 36 | FLT3 | 1.07236480 |
| 37 | NLK | 0.97688732 |
| 38 | PHKG1 | 0.96997860 |
| 39 | PHKG2 | 0.96997860 |
| 40 | MAP2K6 | 0.93656510 |
| 41 | GRK5 | 0.88640448 |
| 42 | PASK | 0.87516259 |
| 43 | ZAP70 | 0.84998821 |
| 44 | PRKCQ | 0.78876588 |
| 45 | TESK2 | 0.78732928 |
| 46 | TBK1 | 0.78062816 |
| 47 | MST4 | 0.77996210 |
| 48 | VRK1 | 0.73714619 |
| 49 | LYN | 0.72089498 |
| 50 | EPHA3 | 0.70111418 |
| 51 | TIE1 | 0.69782971 |
| 52 | MAP3K13 | 0.68451166 |
| 53 | INSRR | 0.67818116 |
| 54 | CAMKK1 | 0.67687072 |
| 55 | CDK8 | 0.66808998 |
| 56 | STK11 | 0.65778046 |
| 57 | RPS6KA5 | 0.65371252 |
| 58 | TGFBR1 | 0.64954519 |
| 59 | MAPKAPK5 | 0.64486809 |
| 60 | BTK | 0.63136331 |
| 61 | IKBKE | 0.61883146 |
| 62 | GRK7 | 0.61371213 |
| 63 | DAPK1 | 0.60226897 |
| 64 | JAK3 | 0.59329298 |
| 65 | ERN1 | 0.58528764 |
| 66 | DAPK2 | 0.57374208 |
| 67 | MAPK7 | 0.57032885 |
| 68 | STK16 | 0.53608643 |
| 69 | JAK1 | 0.52962970 |
| 70 | PRKCH | 0.52866718 |
| 71 | ADRBK1 | 0.52132659 |
| 72 | HCK | 0.50973018 |
| 73 | VRK2 | 0.50928558 |
| 74 | IGF1R | 0.50598984 |
| 75 | OXSR1 | 0.48480876 |
| 76 | OBSCN | 0.47310928 |
| 77 | PIK3CA | 0.47271937 |
| 78 | ABL1 | 0.42593149 |
| 79 | PIK3CG | 0.41619079 |
| 80 | TRPM7 | 0.40222029 |
| 81 | BMPR2 | 0.39256250 |
| 82 | IRAK1 | 0.39140254 |
| 83 | RPS6KB2 | 0.37833187 |
| 84 | CHUK | 0.37345616 |
| 85 | RIPK4 | 0.35351823 |
| 86 | PRKCA | 0.34966308 |
| 87 | CSNK1G3 | 0.34842820 |
| 88 | LMTK2 | 0.34700002 |
| 89 | PRKCD | 0.34659555 |
| 90 | PKN1 | 0.32032008 |
| 91 | AKT2 | 0.29727878 |
| 92 | CSNK1D | 0.28059491 |
| 93 | CSNK2A1 | 0.27548591 |
| 94 | CDK4 | 0.27293542 |
| 95 | MAPK11 | 0.25362847 |
| 96 | NME2 | 0.25072442 |
| 97 | ABL2 | 0.24022783 |
| 98 | TYK2 | 0.23951914 |
| 99 | CDK19 | 0.23878623 |
| 100 | CSNK1A1 | 0.23291831 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 3.66768812 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.60148652 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.47177591 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.45958213 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.43803958 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 3.43624401 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.83495833 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.58383957 |
| 9 | RNA polymerase_Homo sapiens_hsa03020 | 2.48114202 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.21811801 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.12284661 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.10687670 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.09361084 |
| 14 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.08042874 |
| 15 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.84001535 |
| 16 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.83119651 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.78169647 |
| 18 | Parkinsons disease_Homo sapiens_hsa05012 | 1.69903640 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.67733139 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.57453799 |
| 21 | Proteasome_Homo sapiens_hsa03050 | 1.56766210 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.56089272 |
| 23 | Phototransduction_Homo sapiens_hsa04744 | 1.55857319 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.47339002 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.41259292 |
| 26 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.36693384 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.32579694 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.26217662 |
| 29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.26189672 |
| 30 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.24445287 |
| 31 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.19567242 |
| 32 | RNA degradation_Homo sapiens_hsa03018 | 1.18632076 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.17907291 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.15534348 |
| 35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.13347452 |
| 36 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.10111138 |
| 37 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.09106724 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.06532358 |
| 39 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.05209853 |
| 40 | Alzheimers disease_Homo sapiens_hsa05010 | 1.02773673 |
| 41 | Homologous recombination_Homo sapiens_hsa03440 | 0.99083078 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.98702146 |
| 43 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.95773352 |
| 44 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.95762514 |
| 45 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.94466578 |
| 46 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.93855482 |
| 47 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.92942300 |
| 48 | Huntingtons disease_Homo sapiens_hsa05016 | 0.91600488 |
| 49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.89070152 |
| 50 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.88410661 |
| 51 | Purine metabolism_Homo sapiens_hsa00230 | 0.85445081 |
| 52 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.85042627 |
| 53 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.80859240 |
| 54 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.80492868 |
| 55 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.78054472 |
| 56 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.77988468 |
| 57 | Peroxisome_Homo sapiens_hsa04146 | 0.69142084 |
| 58 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.68679530 |
| 59 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.68621065 |
| 60 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.67909231 |
| 61 | Basal transcription factors_Homo sapiens_hsa03022 | 0.67715750 |
| 62 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.66849309 |
| 63 | Olfactory transduction_Homo sapiens_hsa04740 | 0.59133631 |
| 64 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.57463802 |
| 65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.57041198 |
| 66 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.55490492 |
| 67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.54984607 |
| 68 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.54280493 |
| 69 | Salivary secretion_Homo sapiens_hsa04970 | 0.52235714 |
| 70 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.50459107 |
| 71 | Retinol metabolism_Homo sapiens_hsa00830 | 0.46336014 |
| 72 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.44051981 |
| 73 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.42062169 |
| 74 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.41776077 |
| 75 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.41666833 |
| 76 | Base excision repair_Homo sapiens_hsa03410 | 0.40945218 |
| 77 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.40208028 |
| 78 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.40182361 |
| 79 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.39742003 |
| 80 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38957759 |
| 81 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.37064577 |
| 82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.36674747 |
| 83 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.36430286 |
| 84 | Taste transduction_Homo sapiens_hsa04742 | 0.36180750 |
| 85 | ABC transporters_Homo sapiens_hsa02010 | 0.36017887 |
| 86 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.35421610 |
| 87 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.35217423 |
| 88 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.35183473 |
| 89 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.34951607 |
| 90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.32659811 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.29240711 |
| 92 | Spliceosome_Homo sapiens_hsa03040 | 0.27787911 |
| 93 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.27431603 |
| 94 | Measles_Homo sapiens_hsa05162 | 0.26947823 |
| 95 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.25982875 |
| 96 | Sulfur relay system_Homo sapiens_hsa04122 | 0.25682783 |
| 97 | DNA replication_Homo sapiens_hsa03030 | 0.25557909 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.22182376 |
| 99 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.21516685 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | 0.21016398 |

